EPHB2 and neoplasm: Using the KRASG12V/TRP53 mutations model, it was shown that: systemic ablation of MEK or ERK kinases in adult mice prevent tumor development but results in an unacceptable toxicity; ablation of c-RAF expression in advanced tumors results in tumor regression, with no development of resistance mechanisms [251].